Roche Discovers Counterfeit Diabetes Devices on Amazon, Posing Health Risks

Roche Discovers Counterfeit Diabetes Devices on Amazon, Posing Health Risks

Marcelo Silva
2 min read

Roche Discovers Counterfeit Accu-Chek Diabetes Devices Sold on Amazon, Posing Health Risks

Roche, a prominent biotech company, has uncovered counterfeit versions of its Accu-Chek diabetes medical devices being distributed through Amazon, potentially endangering patients across the United States. These fraudulent devices, used for measuring blood glucose levels, are suspected to be expired or nearly expired items repackaged with fake labels and expiration dates. The sale of these counterfeit test strips could yield inaccurate blood glucose readings, leading to severe complications such as high blood sugar and incorrect insulin dosages, posing significant health hazards to individuals with diabetes. Roche has taken legal action by filing a federal lawsuit against manufacturers and sellers in India, prompting a temporary restraining order to stop the sale of these counterfeit products. Despite Amazon not being named as a defendant in the case, Roche asserts that the counterfeit devices were stored in Amazon warehouses nationwide, ready to be swiftly delivered to consumers.

Key Takeaways

  • Roche uncovers counterfeit Accu-Chek diabetes devices being sold on Amazon, posing health risks to patients.
  • Counterfeiters from India are accused of repackaging expired products with counterfeit Roche labels and fake expiration dates.
  • Roche initiates legal action in May, resulting in a temporary restraining order against the counterfeit sellers.
  • Amazon, while not directly involved, stored the counterfeit devices in its warehouses as part of the Fulfillment by Amazon program.
  • Roche launches an investigation in response to information from a whistleblower about the counterfeit products in March.


The revelation of counterfeit Roche Accu-Chek devices on Amazon exposes vulnerabilities in global supply chains and e-commerce platforms. The primary cause stems from the illicit repackaging and sale of expired products by Indian counterfeiters, taking advantage of Amazon's Fulfillment by Amazon program. Immediate repercussions include health risks for U.S. patients and legal consequences for the counterfeiters. Long-term effects could lead to a reformation of regulatory oversight for online marketplaces and an improvement in supply chain security. Roche's legal action and the issuance of a restraining order signify a strengthening of controls, potentially influencing future e-commerce regulations and consumer protection laws.

Did You Know?

  • Accu-Chek Diabetes Medical Devices: Accu-Chek is a brand of medical devices, specifically glucose monitoring systems, utilized by individuals managing diabetes to measure their blood glucose levels, aiding in determining appropriate insulin dosages and dietary adjustments.
  • Hyperglycemia: This term denotes high blood glucose levels. When managing diabetes, maintaining blood glucose within a specific range is crucial. Elevated levels can trigger serious complications such as diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS), which can be life-threatening without prompt treatment.
  • Fulfillment by Amazon (FBA): FBA is an Amazon service allowing sellers to store their products in Amazon's fulfillment centers. Amazon takes charge of storage, packaging, shipping, customer service, and returns for these items, giving sellers the advantage of Amazon's robust logistics network for faster delivery and improved customer service, ultimately boosting their sales potential.

You May Also Like

This article is submitted by our user under the News Submission Rules and Guidelines. The cover photo is computer generated art for illustrative purposes only; not indicative of factual content. If you believe this article infringes upon copyright rights, please do not hesitate to report it by sending an email to us. Your vigilance and cooperation are invaluable in helping us maintain a respectful and legally compliant community.

Subscribe to our Newsletter

Get the latest in enterprise business and tech with exclusive peeks at our new offerings